Medicare will cover Alzheimer's disease treatment Leqembi, but lawmakers have questions on the agency's approach and the drug's high cost.
Payer
Gold Kidney Health Plan, a Medicare Advantage insurer offering chronic special needs plans, is expanding to Florida in 2024.
As Blue Cross and Blue Shield of Minnesota prepares to move out of its suburban Minneapolis headquarters, the company has discovered two time capsules buried underneath the building, Twin Cities Pioneer Press reported July 11.
About two-thirds of patients who take popular weight loss drugs end their regimen within a year, according to a Prime Therapeutics study released July 11.
Cigna has received final approval from a federal court in Connecticut on a $300,000 class settlement with plaintiffs who alleged the company violated its fiduciary duties under ERISA by overcharging for laboratory services from certain providers.
The Cigna Group's network of behavioral health providers grew by more than 30 percent in 2022, according to the company's 2022 Environmental, Social, and Governance Report.
Total risk adjustment payments in individual and small group insurance plans increased in 2022, according to new data from CMS.
Cigna is adding three Humira biosimilars to its formulary beginning Sept. 1.
GLP-1 drugs like Ozempic and Wegovy are contributing to increasing premium rates in Michigan's small-group and individual insurance markets, the Detroit Free-Press reported July 10.
BlueCross BlueShield of Tennessee reported $21.8 million in net income for 2022, down from $521.1 million in 2021.
